SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as anticipation builds around the readout of its Phase 3 HOPE-3 trial data for DMD, with some suggesting a potential data leak due to recent price action. The community is closely watching for news, speculating on positive outcomes and a potential short squeeze, while also debating the impact of key figures like Martin Shkreli's short position on the stock.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending amid bullish sentiment and anticipation surrounding upcoming earnings, with community members pointing to a large cash pile and potential catalysts. Conversations also highlight past figures like Roaring Kitty and Michael Burry. Speculation about the warrants outpacing the stock is fueling discussion of a potential breakout.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

CrowdStrike is trending amid analyst upgrades and discussions around its AI-driven cybersecurity platform. Community members are debating valuation, growth potential, and potential resistance levels. Positive sentiment surrounds its partnerships and position in the cybersecurity sector.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE is trending as the community rallies around its meme-driven identity and "working for bags" mentality. Community members are emphasizing the importance of unity and are actively promoting the project across social platforms like TikTok and Reddit. The broader discussion includes anticipation for a potential market rebound and the resurgence of OG memes.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

COIN is trending as the stock price is highly correlated with Bitcoin and Ethereum, as well as potential institutional adoption that may result in significant inflows. Community members are actively discussing short-term bounce potential and key resistance levels, with some anticipating a rise toward $300, while others mention a potential Trump advisor becoming the next Fed Chair which could be bullish for crypto regulation.

Sailana Inu, the sister of legendary Saitama Inu, is bringing back the Wolfpack and OG community vibes that previously sent Saitama to a $7 billion marketcap in 2021. The power of community mixed with great leadership is what will take this project to great heights. Join the movement, join the pack, become apart of the Sailana Army . Together, we will create something that will go down in history, and something that will be talked about years from now.

Sailana Inu

Sailana Inu is trending with community members highlighting upcoming developments like WolfSWAP and WolfDAO, with some suggesting it has the potential to be a leading memecoin. The community, known as the Wolfpack, expresses strong conviction and dedication to building the project, generating consistent buzz and aiming for significant growth.

Okta, Inc. engages in the provision of an identity management platform for enterprises. It operates through the United States and International geographical segments. The firm's products include single sign-on, multi-factor authentication, access gateway, API access management, authentication, adaptive MFA and lifecycle management. The company was founded by Todd McKinnon and J. Frederic Kerrest in 2009 and is headquartered in San Francisco, CA.

Okta Inc - Ordinary Shares - Class A

Okta Inc

Okta is trending following its latest earnings report, with community discussions focused on the seemingly negative price action despite the company beating expectations and raising guidance; some believe the stock is undervalued while others point to its high P/E ratio and are waiting for a price correction, while others suggest the market is rigged and the stock is manipulated.

Klarna Group Plc operates as an investment holding company. It provides an e-commerce payment solutions for merchants and shoppers. The firm connect an array of different financial services and commerce organizations, from PSPs, traditional banks, card networks and open banking providers, to commerce enablers, technology partners, in-store payments providers and shipping and return logistics providers. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna ($KLAR) is trending due to discussions around Buy Now Pay Later (BNPL) usage hitting record highs, especially during Black Friday and Cyber Monday, with community members highlighting a surge in Klarna-specific usage. Concerns are being raised about consumer debt and potential risks associated with BNPL models, while others point out Klarna's expansion into new payment methods and partnerships, like the recent stablecoin launch, as potential growth drivers. Investors are weighing the impact of increasing BNPL adoption on consumer credit risk and the broader economy.

Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel.

Polyrizon Ltd.

Polyrizon Ltd. Ordinary Shares

PLRZ is trending due to a manufacturing milestone announcement regarding its nasal spray product, leading to significant volatility and a surge in trading volume. Community discussions revolve around the stock's potential for a short squeeze and its low float, while some traders express concerns about potential dilution and an impending price drop. The stock's extreme price fluctuations and high trading volume have captured the attention of day traders and investors alike.

PAW Chain has launched the world’s first Layer 3-centric blockchain, enhancing scalability and inter-chain operability across networks. The roadmap features a decentralized exchange, merchant services, and a DAO, all optimized for high-volume, low-cost transactions. Leveraging smart contracts and EVM compatibility, PAW Chain is set to transform digital finance by providing secure, efficient solutions, allowing any project to go multi-chain, underscored by a community-driven governance model and rigorous security standards including regular security audits.

PAW is trending due to its shift towards providing infrastructure for businesses and bridging Web2 with Web3, with the community highlighting the potential for real-world utility and long-term growth. Discussions center on PAW Chain's ecosystem development, enterprise-focused tools, and strategic branding, as it aims to become a foundational layer for future digital systems. Some community members express excitement about ongoing developments, hinting at potential partnerships and a major rebrand on the horizon.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MIRM Enrolls First Patient in Phase II Fragile X Syndrome Study

Mirum enrolls the first participant in its phase II BLOOM study investigating MRM-3379 for treating Fragile X syndrome.

JNJ Gets EU Nod for Imaavy in Generalized Myasthenia Gravis

J&J gains EU approval for Imaavy, the first FcRn blocker for adults and adolescents with generalized myasthenia gravis.

ARCT Stock Plunges 59% in Three Months: Here's What You Need to Know

Arcturus Therapeutics' stock slides 59%, primarily due to mixed interim results from the phase II study of its investigational inhaled cystic fibrosis therapy, ARCT-032.

Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a Bet

The average brokerage recommendation (ABR) for Adma Biologics (ADMA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Legal & General Group Plc Acquires 37,699 Shares of ADMA Biologics Inc $ADMA

Legal & General Group Plc raised its holdings in shares of ADMA Biologics Inc (NASDAQ:ADMA - Free Report) by 5.6% in the second quarter, according to the company in its most recent disclosure with...

Ensign Peak Advisors Inc Acquires 80,462 Shares of ADMA Biologics Inc $ADMA

Ensign Peak Advisors Inc boosted its stake in shares of ADMA Biologics Inc (NASDAQ:ADMA - Free Report) by 122.7% during the 2nd quarter, according to its most recent disclosure with the Securities...

Wall Street Analysts Think Adma Biologics (ADMA) Could Surge 60.24%: Read This Before Placing a Bet

The consensus price target hints at a 60.2% upside potential for Adma Biologics (ADMA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Franklin Resources Inc. Boosts Stock Holdings in ADMA Biologics Inc $ADMA

Franklin Resources Inc. grew its position in ADMA Biologics Inc (NASDAQ:ADMA - Free Report) by 66.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the...

American Century Companies Inc. Buys 358,627 Shares of ADMA Biologics Inc $ADMA

American Century Companies Inc. raised its stake in ADMA Biologics Inc (NASDAQ:ADMA - Free Report) by 8.4% during the second quarter, according to its most recent filing with the Securities and...

Adma Biologics (ADMA) Upgraded to Buy: Here's What You Should Know

Adma Biologics (ADMA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Current Price	$19.25
Prev Close	$19.38
Open	$19.43
Dividend Yield	0.00%
50-Day Moving Average	$15.63
Beta	1.27
Avg. Volume	4.02M
PE Ratio	22.61

52-Week High	$25.67
52-Week Low	$13.50
Market Capitalization	$4.61B
EPS (Annual)	$0.8123
Price to Book	10.64
Revenue Per Employee	$622,560.58
Enterprise Value/EBITDA	N/A

ADMA
Adma Biologics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ADMA News

ADMAAdma Biologics Inc